451 related articles for article (PubMed ID: 19778662)
1. The role of biomarkers and genetics in peripheral arterial disease.
McDermott MM; Lloyd-Jones DM
J Am Coll Cardiol; 2009 Sep; 54(14):1228-37. PubMed ID: 19778662
[TBL] [Abstract][Full Text] [Related]
2. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
McDermott MM; Greenland P; Green D; Guralnik JM; Criqui MH; Liu K; Chan C; Pearce WH; Taylor L; Ridker PM; Schneider JR; Martin G; Rifai N; Quann M; Fornage M
Circulation; 2003 Jul; 107(25):3191-8. PubMed ID: 12810614
[TBL] [Abstract][Full Text] [Related]
3. Statin use and functional decline in patients with and without peripheral arterial disease.
Giri J; McDermott MM; Greenland P; Guralnik JM; Criqui MH; Liu K; Ferrucci L; Green D; Schneider JR; Tian L
J Am Coll Cardiol; 2006 Mar; 47(5):998-1004. PubMed ID: 16516084
[TBL] [Abstract][Full Text] [Related]
4. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
Beckman JA; Preis O; Ridker PM; Gerhard-Herman M
Am J Cardiol; 2005 Nov; 96(10):1374-8. PubMed ID: 16275181
[TBL] [Abstract][Full Text] [Related]
5. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
[TBL] [Abstract][Full Text] [Related]
6. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
Paraskevas KI; Giannoukas AD; Mikhailidis DP
Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs.
de Haro Miralles J; Martínez-Aguilar E; Florez A; Varela C; Bleda S; Acin F
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):107-12. PubMed ID: 19376804
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease.
McDermott MM; Guralnik JM; Greenland P; Green D; Liu K; Ridker PM; Chan C; Criqui MH; Ferrucci L; Taylor LM; Pearce WH; Schneider JR; Oskin SI
J Am Geriatr Soc; 2004 Nov; 52(11):1888-94. PubMed ID: 15507067
[TBL] [Abstract][Full Text] [Related]
9. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy.
Makowsky MJ; McAlister FA; Galbraith PD; Southern DA; Ghali WA; Knudtson ML; Tsuyuki RT;
Am Heart J; 2008 Feb; 155(2):348-55. PubMed ID: 18215607
[TBL] [Abstract][Full Text] [Related]
10. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
Coppola G; Novo S
Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
[TBL] [Abstract][Full Text] [Related]
11. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
[TBL] [Abstract][Full Text] [Related]
12. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
Shankar A; Li J; Nieto FJ; Klein BE; Klein R
Am Heart J; 2007 Sep; 154(3):495-501. PubMed ID: 17719297
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
[TBL] [Abstract][Full Text] [Related]
14. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Eur Heart J; 2007 Feb; 28(3):354-62. PubMed ID: 17213229
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment in the patient with established peripheral arterial disease.
Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
[TBL] [Abstract][Full Text] [Related]
17. The role of fibrinogen and fibrinolysis in peripheral arterial disease.
Paraskevas KI; Baker DM; Vrentzos GE; Mikhailidis DP
Thromb Res; 2008; 122(1):1-12. PubMed ID: 17669476
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in peripheral arterial disease.
Thomas JC; Vohra RS; Beer S; Bhatti K; Ponnambalam S; Homer-Vanniasinkam S
Trends Cardiovasc Med; 2009 Jul; 19(5):147-51. PubMed ID: 20005473
[TBL] [Abstract][Full Text] [Related]
19. Can functional performance be used as a simple prognostic indicator in peripheral arterial disease?
Olin JW
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):686-7. PubMed ID: 18779831
[TBL] [Abstract][Full Text] [Related]
20. Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.
Reich LM; Heiss G; Boland LL; Hirsch AT; Wu K; Folsom AR
Vasc Med; 2007 Nov; 12(4):267-73. PubMed ID: 18048462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
